Elanco Purchases Two Agrilabs Brands

Elanco Purchases Two Agrilabs Brands

Elanco expands vaccine presence with Titanium and Master Guard purchase

Elanco, the animal health division of Eli Lilly and Company, has announced the purchase of Titanium and Master Guard brands from AgriLabs. These cattle vaccine brands will complement Elanco's growing vaccine portfolio, the company said.

Elanco will continue to deliver these brands in the same manner producers have come to expect and will work closely with AgriLabs to ensure a seamless transition, an announcement said. Elanco will also support all 2013 programs and pricing, and customers should continue to place orders through existing channels.

Elanco expands vaccine presence with Titanium and Master Guard purchase

"At Elanco, we are committed to providing innovative solutions to enhance food production and companion animal care. We are pleased our growing vaccine portfolio and pipeline will offer Elanco customers a broader array of options to better meet their specific needs for disease prevention," said Elanco President Jeff Simmons.

In the next few decades, global population is expected to exceed 9 billion, and 3 billion will move into the middle class, the fastest middle class growth in our history. With the growing affluence, will come a 60 percent increase in demand for meat, milk and eggs, according to the U.N. Food and Agriculture Organization.

Rob Aukerman, president U.S. operations at Elanco says this means Elanco must continue to provide innovative solutions that will help producers increase the affordability and availability of animal protein.

"We have diversified our portfolio and sources of innovation to deliver more options and solutions to our customers," he said.

AgriLabs has previously introduced products for beef, dairy and companion animal industries. The wholly owned ProLabs division focuses on new product development of companion animal products into the over-the-counter channel. The VaxLiant company is a joint venture with Benchmark Biolabs designed to modernize how vaccines deliver antigens to prevent disease with its ENABL and Biomize adjuvants.

TAGS: Regulatory
Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish